These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 1332849)

  • 41. Identification of binding domains of the growth hormone-releasing hormone receptor by analysis of mutant and chimeric receptor proteins.
    DeAlmeida VI; Mayo KE
    Mol Endocrinol; 1998 May; 12(5):750-65. PubMed ID: 9605937
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Peptide specificity for stimulation of corticotropin secretion: activation of overlapping pathways by the vasoactive intestinal peptide family and corticotropin-releasing factor.
    Westendorf JM; Schonbrunn A
    Endocrinology; 1985 Jun; 116(6):2528-35. PubMed ID: 2859986
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gonadotropin receptor occupancy and stimulation of cAMP and testosterone production by purified Leydig cells: critical dependence on cell concentration.
    Browne ES; Flasch MV; Sohal GS; Bhalla VK
    Mol Cell Endocrinol; 1990 Mar; 70(1):49-63. PubMed ID: 2160383
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibitory action of forskolin on adenylate cyclase activity and cyclic AMP generation.
    Khanum A; Dufau ML
    J Biol Chem; 1986 Sep; 261(25):11456-9. PubMed ID: 3017932
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Homologous down-regulation of growth hormone-releasing hormone receptor messenger ribonucleic acid levels.
    Aleppo G; Moskal SF; De Grandis PA; Kineman RD; Frohman LA
    Endocrinology; 1997 Mar; 138(3):1058-65. PubMed ID: 9048609
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of GHRH and peptides from the vasoactive intestinal peptide family on cAMP production of human cancer cell lines in vitro.
    Csernus V; Schally AV; Groot K
    J Endocrinol; 1999 Nov; 163(2):269-80. PubMed ID: 10556777
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stimulation and inhibition by LHRH analogues of cultured rat Leydig cell function and lack of effect on mouse Leydig cells.
    Hunter MG; Sullivan MH; Dix CJ; Aldred LF; Cooke BA
    Mol Cell Endocrinol; 1982 Jun; 27(1):31-44. PubMed ID: 6286388
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multistep regulation of Leydig cell function.
    Dufau ML; Khanum A; Winters CA; Tsai-Morris CH
    J Steroid Biochem; 1987; 27(1-3):343-50. PubMed ID: 2826891
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Is deglycosylated human chorionic gonadotropin an antagonist to human chorionic gonadotropin? Characterization of deglycosylated human chorionic gonadotropin action in two testicular interstitial cell fractions.
    Browne ES; Flasch MV; Sairam MR; Bhalla VK
    Biochim Biophys Acta; 1990 Mar; 1033(3):226-34. PubMed ID: 2156567
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression and effect of insulin-like growth factor I on rat fetal Leydig cell function and differentiation.
    Rouiller-Fabre V; Lecref L; Gautier C; Saez JM; Habert R
    Endocrinology; 1998 Jun; 139(6):2926-34. PubMed ID: 9607803
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interaction of peptides related to VIP and secretin with guinea pig pancreatic acini.
    Zhou ZC; Gardner JD; Jensen RT
    Am J Physiol; 1989 Feb; 256(2 Pt 1):G283-90. PubMed ID: 2465694
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Selective photolabeling of high and low affinity binding sites for vasoactive intestinal peptide (VIP): evidence for two classes of covalent VIP-receptor complexes in intestinal cell membranes.
    Robichon A; Marie JC
    Endocrinology; 1987 Mar; 120(3):978-85. PubMed ID: 3026793
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vasoactive intestinal peptide receptor antagonists in rat seminal vesicle membranes.
    Rodríguez-Pena MS; Guijarro LG; Prieto JC
    Eur J Pharmacol; 1991 Nov; 208(3):207-12. PubMed ID: 1663044
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antagonistic analogs of growth hormone releasing hormone (GHRH) inhibit cyclic AMP production of human cancer cell lines in vitro.
    Csernus V; Schally AV; Groot K
    Peptides; 1999; 20(7):843-50. PubMed ID: 10477085
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Different sites of action of arachidonic acid on steroidogenesis in rat Leydig cells.
    Marinero MJ; Colas B; Prieto JC; López-Ruiz MP
    Mol Cell Endocrinol; 1996 Apr; 118(1-2):193-200. PubMed ID: 8735605
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The stimulation of rat Leydig cell steroidogenesis by human ovarian steroidogenesis-inducing protein (SIP) may not require endogenous cAMP.
    Keck C; Khan SA; Rommerts FF; Spiteri-Grech J; Sharma OP; Nieschlag E
    Exp Clin Endocrinol; 1993; 101(2):94-100. PubMed ID: 8405145
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prolactin and antiprolactin receptor antibody inhibit steroidogenesis by purified rat Leydig cells in culture.
    Barkey RJ; Weiss-Messer E; Mandel S; Gahnem F; Amit T
    Mol Cell Endocrinol; 1987 Jul; 52(1-2):71-80. PubMed ID: 3622921
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vasoactive intestinal peptide stimulates androgen biosynthesis by cultured neonatal testicular cells.
    Kasson BG; Lim P; Hsueh AJ
    Mol Cell Endocrinol; 1986 Nov; 48(1):21-9. PubMed ID: 2430845
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vasoactive intestinal peptide: a novel stimulator of steroidogenesis by cultured rat granulosa cells.
    Davoren JB; Hsueh AJ
    Biol Reprod; 1985 Aug; 33(1):37-52. PubMed ID: 2998497
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adrenocorticotropin, vasoactive intestinal polypeptide, growth hormone-releasing factor, and dynorphin compete for common receptors in brain and adrenal.
    Li ZG; Queen G; LaBella FS
    Endocrinology; 1990 Mar; 126(3):1327-33. PubMed ID: 1968378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.